Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Medpace EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Medpace's EV/EBITDA was 30.9× on Nov 11, 2026, against 32.4× a year earlier. Over the last 5 years it ranged from 18.3× to 37.4×, with a median of 26.0×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 30.9× | +0.3 |
| 2025 | Dec 31, 2025 | 30.6× | +7.0 |
| 2024 | Dec 31, 2024 | 23.7× | −4.9 |
| 2023 | Dec 29, 2023 | 28.6× | +2.4 |
| 2022 | Dec 30, 2022 | 26.1× | −11.2 |
| 2021 | Dec 31, 2021 | 37.4× | +5.2 |
| 2020 | Dec 31, 2020 | 32.1× | +7.9 |
| 2019 | Dec 31, 2019 | 24.2× | +1.2 |
| 2018 | Dec 31, 2018 | 23.0× | −1.3 |
| 2017 | Dec 29, 2017 | 24.3× | −17.1 |
| 2016 | Dec 30, 2016 | 41.5× | – |
See a number that looks wrong?